FDA Inspection 813385 — Apotex Inc.

Apotex Inc. — FEI 3001617666

The FDA completed an inspection of Apotex Inc. on Oct 26, 2012 in Richmond Hill. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Oct 26, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Richmond Hill (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.